TOTAL GUT PROBIOTIC - Trademark Details
Status: 733 - Fourth Extension - Granted
Serial Number
88170576
Word Mark
TOTAL GUT PROBIOTIC
Status
733 - Fourth Extension - Granted
Status Date
2021-12-10
Filing Date
2018-10-26
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-10-15
Attorney Name
Law Office Assigned Location Code
M90
Employee Name
DUBRAY, KATHERINE M
Statements
Disclaimer with Predetermined Text
"GUT PROBIOTIC"
Goods and Services
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and/or minerals and/or essential fatty acids and/or probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; preparations in the nature of a vaginal probiotic for the treatment and/or prevention of bacterial or fungal vaginal infection; nutraceuticals for the treatment and/or prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibers in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibers in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, including, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for improving the physical well-being of humans, namely, reducing inflammation and pain; supplements, namely, dietary supplements, for medical use and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and/or nutritional and dietary supplements; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplements, namely, probiotic compositions; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and/or bacterial probiotics, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, probiotic compositions; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; diagnostic test kit comprised of medical diagnostic reagents and assays for the detection of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; diagnostic colon test kit comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Crohn's disease, ulcerative colitis, and irritable bowel syndrome; diagnostic colon cancer test kit comprised of medical diagnostic reagents and assays; diagnostic colorectal cancer screening test kit comprised of medical diagnostic reagents and assays; all of the aforementioned supplements and pharmaceutical products for human consumption containing probiotics; all of the aforementioned diagnostic kits testing levels of probiotics; Educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and how to have and maintain and/or monitor a heathy gastrointestinal tract; educational services, namely, providing online instruction and distribution of educational materials in connection therewith featuring information regarding the gastrointestinal tract and how to have and maintain and/or monitor a heathy large intestine; Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; Medical diagnostic testing services to apprise individuals and/or animals of the status of the gastrointestinal tract; Medical diagnostic testing services to apprise individuals and/or animals of the status of the large intestine; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the gastrointestinal tract; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the large intestine
Goods and Services
Educational services, namely, providing online courses of instruction and distribution of educational materials in connection therewith in the field of the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; educational services, namely, providing online courses of instruction and distribution of educational materials in connection therewith in the field of the gastrointestinal tract and the existence and reason for bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; educational services, namely, providing online courses of instruction and distribution of educational materials in connection therewith in the field of the gastrointestinal tract and how to have and maintain and/or monitor a heathy gastrointestinal tract; educational services, namely, providing online courses of instruction and distribution of educational materials in connection therewith in the field of the gastrointestinal tract and how to have and maintain and/or monitor a heathy large intestine
Goods and Services
Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the gastrointestinal tract; Medical diagnostic testing services to detect bacteria, fungus, microorganisms, probiotics, cancer and/or pathogens in the large intestine; Medical diagnostic testing services to apprise individuals and/or animals of the status of the gastrointestinal tract; Medical diagnostic testing services to apprise individuals and/or animals of the status of the large intestine; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the gastrointestinal tract; providing medical information comprised of a personalized report comparing detected levels of bacteria, fungus, microorganisms, probiotics, cancer and/or pathogen in the large intestine
Classification Information
International Class
041 - Education; providing of training; entertainment; sporting and cultural activities. - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes
100, 101, 107
Class Status Code
6 - Active
Class Status Date
2019-08-30
Primary Code
041
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-08-30
Primary Code
044
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
11 - 1st New Owner Before Publication
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
16 - Limited Liability Company
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Brian E. Turung
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2018-11-09 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-01-30 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
2019-02-04 | ASSIGNED TO EXAMINER |
2019-03-01 | NON-FINAL ACTION WRITTEN |
2019-03-01 | NON-FINAL ACTION E-MAILED |
2019-03-01 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2019-08-29 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2019-08-29 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2019-08-30 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2019-09-06 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2019-09-09 | ASSIGNED TO LIE |
2019-09-25 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2019-10-15 | PUBLISHED FOR OPPOSITION |
2019-10-15 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2019-12-10 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2020-06-10 | TEAS EXTENSION RECEIVED |
2020-06-10 | EXTENSION 1 FILED |
2020-06-10 | EXTENSION 1 GRANTED |
2020-06-12 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2020-10-05 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
2020-10-05 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2020-10-05 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2020-10-05 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2020-10-05 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
2020-12-10 | TEAS EXTENSION RECEIVED |
2020-12-10 | EXTENSION 2 FILED |
2020-12-10 | EXTENSION 2 GRANTED |
2020-12-12 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-06-09 | TEAS EXTENSION RECEIVED |
2021-06-09 | EXTENSION 3 FILED |
2021-06-09 | EXTENSION 3 GRANTED |
2021-06-11 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
2021-12-10 | TEAS EXTENSION RECEIVED |
2021-12-10 | EXTENSION 4 FILED |
2021-12-10 | EXTENSION 4 GRANTED |